BLUEJAY DIAGNOSTICS INC (BJDX) Fundamental Analysis & Valuation

NASDAQ:BJDX • US0956336087

Current stock price

1.94 USD
-0.01 (-0.51%)
Last:

This BJDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BJDX Profitability Analysis

1.1 Basic Checks

  • BJDX had negative earnings in the past year.
  • In the past year BJDX has reported a negative cash flow from operations.
  • BJDX had negative earnings in each of the past 5 years.
  • In the past 5 years BJDX always reported negative operating cash flow.
BJDX Yearly Net Income VS EBIT VS OCF VS FCFBJDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -410.48%, BJDX is not doing good in the industry: 95.11% of the companies in the same industry are doing better.
  • The Return On Equity of BJDX (-543.59%) is worse than 84.24% of its industry peers.
Industry RankSector Rank
ROA -410.48%
ROE -543.59%
ROIC N/A
ROA(3y)-195.93%
ROA(5y)-136.14%
ROE(3y)-263.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BJDX Yearly ROA, ROE, ROICBJDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BJDX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BJDX Yearly Profit, Operating, Gross MarginsBJDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BJDX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BJDX has been increased compared to 1 year ago.
  • BJDX has more shares outstanding than it did 5 years ago.
  • BJDX has a better debt/assets ratio than last year.
BJDX Yearly Shares OutstandingBJDX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
BJDX Yearly Total Debt VS Total AssetsBJDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -14.70, we must say that BJDX is in the distress zone and has some risk of bankruptcy.
  • BJDX has a Altman-Z score of -14.70. This is amonst the worse of the industry: BJDX underperforms 86.41% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that BJDX is not too dependend on debt financing.
  • BJDX has a better Debt to Equity ratio (0.00) than 73.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.7
ROIC/WACCN/A
WACCN/A
BJDX Yearly LT Debt VS Equity VS FCFBJDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • BJDX has a Current Ratio of 2.92. This indicates that BJDX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.92, BJDX is in line with its industry, outperforming 55.98% of the companies in the same industry.
  • A Quick Ratio of 2.92 indicates that BJDX has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.92, BJDX is doing good in the industry, outperforming 63.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.92
BJDX Yearly Current Assets VS Current LiabilitesBJDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BJDX Growth Analysis

3.1 Past

  • BJDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.60%, which is quite impressive.
EPS 1Y (TTM)97.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • BJDX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.65% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y67.68%
EPS Next 2Y30.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BJDX Yearly Revenue VS EstimatesBJDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2025 2026 2M 4M 6M 8M
BJDX Yearly EPS VS EstimatesBJDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -2K -4K -6K -8K

More info and screens

Find the best growth stocksShow best growing peers

1

4. BJDX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BJDX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BJDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BJDX Price Earnings VS Forward Price EarningsBJDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BJDX Per share dataBJDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BJDX's earnings are expected to grow with 30.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.65%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BJDX Dividend Analysis

5.1 Amount

  • No dividends for BJDX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BJDX Fundamentals: All Metrics, Ratios and Statistics

BLUEJAY DIAGNOSTICS INC

NASDAQ:BJDX (3/17/2026, 9:38:41 AM)

1.94

-0.01 (-0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-28
Earnings (Next)N/A
Inst Owners4.33%
Inst Owner Change-100%
Ins Owners2.54%
Ins Owner Change0%
Market Cap1.88M
Revenue(TTM)N/A
Net Income(TTM)-20.07M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)-134.41
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-6.53
FCFYN/A
OCF(TTM)-6.53
OCFYN/A
SpS0
BVpS3.81
TBVpS3.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -410.48%
ROE -543.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-195.93%
ROA(5y)-136.14%
ROE(3y)-263.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -2.81%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.92
Altman-Z -14.7
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)421.46%
Cap/Depr(5y)255.54%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.91%
EPS Next Y67.68%
EPS Next 2Y30.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.27%
OCF growth 3YN/A
OCF growth 5YN/A

BLUEJAY DIAGNOSTICS INC / BJDX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BJDX.


Can you provide the valuation status for BLUEJAY DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to BLUEJAY DIAGNOSTICS INC (BJDX). This can be considered as Overvalued.


How profitable is BLUEJAY DIAGNOSTICS INC (BJDX) stock?

BLUEJAY DIAGNOSTICS INC (BJDX) has a profitability rating of 0 / 10.


How financially healthy is BLUEJAY DIAGNOSTICS INC?

The financial health rating of BLUEJAY DIAGNOSTICS INC (BJDX) is 4 / 10.